Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 173,600
-2,200 (-1.25%)
At close: Oct 10, 2025
Celltrion Market Cap
Celltrion has a market cap or net worth of 38.24 trillion as of October 10, 2025. Its market cap has decreased by -1.42% in one year.
Market Cap
38.24T
Enterprise Value
40.11T
Revenue
3.75T
Ranking
n/a
PE Ratio
78.93
Stock Price
173,600.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 38.24T, an increase of 36,742.28%. That is a compound annual growth rate of 41.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 38.24T | -5.26% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | 48.99T | 102.64% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |
| ABL Bio | 5,258.94B |